ArticleFrontiers in medicine2026

Case Report: Pembrolizumab-associated seronegative sicca syndrome during continued immunotherapy and after drug withdrawal in metastatic urothelial carcinoma.

Yunjung ChoiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.